AVID BIOSERVICES INC (CDMO) Stock Analyst Earnings Estimates
NASDAQ:CDMO - Nasdaq - US05368M1062 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 119.6M 24.71% | 149.3M 24.83% | 139.911M -6.29% | 166.37M 18.91% | 194.26M 16.76% | 234.86M 20.90% | 307.28M 30.84% | 385.63M 25.50% | 482.04M 25.00% | 597.73M 24.00% | |
| EBITDA YoY % growth | 19.88M 27.03% | 10.81M -45.62% | -7.569M -170.02% | 12.718M 268.03% | 28.906M 127.28% | 50.053M 73.16% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 15.4M 26.23% | 3.6M -76.62% | -18.678M -618.83% | -11.578M 38.02% | 4.823M 141.66% | 17.124M 255.05% | 30.728M 79.44% | 48.204M 56.87% | 72.307M 50.00% | 104.6M 44.66% | |
| Operating Margin | 12.88% | 2.41% | -13.35% | -6.96% | 2.48% | 7.29% | 10.00% | 12.50% | 15.00% | 17.50% | |
| EPS YoY % growth | 0.21 425.00% | 0.01 -95.24% | -2.21 -22,200.00% | -0.34 84.65% | -0.06 82.71% | 0.18 413.04% | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 39.56% | -0.03 98.60% | -0.03 66.00% | -0.08 69.78% | -0.03 53.12% | 0.02 174.99% | 0.03 200.00% | -0.02 75.00% | 0.03 220.00% | 0.09 350.00% |
| Revenue Q2Q % growth | 42.741M 26.40% | 48.391M 12.60% | 48.764M 21.39% | 38.95M 16.33% | 50.082M 17.18% | 58.575M 21.05% | 58.324M 19.60% | 47.222M 21.24% | 59.596M 19.00% | 67.467M 15.18% |
| EBITDA Q2Q % growth | 4.556M 7.17% | 6.688M -31.86% | 7.374M 1,903.80% | 2.59M 144.39% | 8.054M 76.78% | 11.335M 69.48% | 12.501M 69.53% | 7.862M 203.55% | 12.982M 61.19% | 17.913M 58.03% |
| EBIT Q2Q % growth | -1.998M 50.03% | 321.637K 124.86% | 117.3K 104.78% | -4.093M 67.60% | 464.61K 123.25% | 3.838M 1,093.27% | 5.353M 4,463.51% | 240.72K 105.88% | 5.127M 1,003.51% | 11.237M 192.78% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.27 -80.00% | -0.12 | -0.15 | -125.28% |
| Q1 2025 Q2Q % growth | -0.09 -200.00% | -0.06 | -0.03 | -60.43% |
| Q4 2024 Q2Q % growth | -1.94 | -0.04 | -1.90 | -4,971.90% |
| Q3 2024 Q2Q % growth | -0.09 -1,000.00% | -0.05 | -0.04 | -68.07% |
| Q2 2024 Q2Q % growth | -0.15 -650.00% | -0.06 | -0.09 | -135.29% |
| Q1 2024 Q2Q % growth | -0.03 -250.00% | -0.03 | 0.00 | -6.95% |
| Q4 2023 Q2Q % growth | 0.00 -100.00% | 0.00 | 0.00 | % |
| Q3 2023 Q2Q % growth | 0.01 -75.00% | -0.04 | 0.05 | 128.01% |
| Q2 2023 Q2Q % growth | -0.02 -133.33% | -0.01 | -0.01 | -292.16% |
| Q1 2023 Q2Q % growth | 0.02 -80.00% | 0.04 | -0.02 | -46.53% |
| Q4 2022 Q2Q % growth | 0.01 125.00% | 0.01 | 0.00 | -1.96% |
| Q3 2022 Q2Q % growth | 0.04 300.00% | 0.04 | 0.00 | -1.96% |
| Q2 2022 Q2Q % growth | 0.06 500.00% | 0.03 | 0.03 | 135.29% |
| Q1 2022 Q2Q % growth | 0.10 66.67% | 0.04 | 0.06 | 161.44% |
| Q4 2021 Q2Q % growth | -0.04 63.64% | 0.01 | -0.05 | -884.31% |
| Q3 2021 Q2Q % growth | 0.01 116.67% | -0.03 | 0.04 | 132.68% |
| Q2 2021 Q2Q % growth | 0.01 133.33% | -0.06 | 0.07 | 117.30% |
| Q1 2021 Q2Q % growth | 0.06 175.00% | -0.08 | 0.14 | 178.43% |
| Q4 2020 Q2Q % growth | -0.11 -450.00% | -0.17 | 0.06 | 33.97% |
| Q3 2020 Q2Q % growth | -0.06 -20.00% | -0.04 | -0.02 | -54.80% |
| Q2 2020 Q2Q % growth | -0.03 40.00% | -0.05 | 0.02 | 43.44% |
| Q1 2020 Q2Q % growth | -0.08 -33.33% | -0.03 | -0.05 | -161.44% |
| Q4 2019 Q2Q % growth | -0.02 | -0.03 | 0.01 | 34.64% |
| Q3 2019 Q2Q % growth | -0.05 | -0.07 | 0.02 | 29.97% |
| Q2 2019 Q2Q % growth | -0.05 | -0.08 | 0.03 | 41.17% |
| Q1 2019 Q2Q % growth | -0.06 | -0.13 | 0.07 | 54.75% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 33.482M 31.84% | 34.477M | -995K | -2.89% |
| Q1 2025 Q2Q % growth | 40.173M 6.49% | 41.579M | -1.406M | -3.38% |
| Q4 2024 Q2Q % growth | 42.975M 7.98% | 42.985M | -10K | -0.02% |
| Q3 2024 Q2Q % growth | 33.815M -11.06% | 34.121M | -306K | -0.90% |
| Q2 2024 Q2Q % growth | 25.395M -26.94% | 33.876M | -8.481M | -25.04% |
| Q1 2024 Q2Q % growth | 37.726M 2.82% | 36.807M | 919K | 2.50% |
| Q4 2023 Q2Q % growth | 39.799M 27.44% | 39.675M | 124K | 0.31% |
| Q3 2023 Q2Q % growth | 38.02M 20.66% | 37.045M | 975K | 2.63% |
| Q2 2023 Q2Q % growth | 34.76M 33.13% | 32.69M | 2.07M | 6.33% |
| Q1 2023 Q2Q % growth | 36.69M 19.32% | 34.112M | 2.578M | 7.56% |
| Q4 2022 Q2Q % growth | 31.23M 13.11% | 29.537M | 1.693M | 5.73% |
| Q3 2022 Q2Q % growth | 31.51M 44.48% | 27.126M | 4.384M | 16.16% |
| Q2 2022 Q2Q % growth | 26.11M 23.98% | 24.503M | 1.607M | 6.56% |
| Q1 2022 Q2Q % growth | 30.75M 21.11% | 28.364M | 2.386M | 8.41% |
| Q4 2021 Q2Q % growth | 27.61M 120.00% | 22.03M | 5.58M | 25.33% |
| Q3 2021 Q2Q % growth | 21.81M 60.49% | 19.45M | 2.36M | 12.13% |
| Q2 2021 Q2Q % growth | 21.06M 15.02% | 15.796M | 5.264M | 33.32% |
| Q1 2021 Q2Q % growth | 25.39M 66.49% | 16.832M | 8.558M | 50.84% |
| Q4 2020 Q2Q % growth | 12.55M -26.44% | 8.946M | 3.604M | 40.29% |
| Q3 2020 Q2Q % growth | 13.59M -1.38% | 15.73M | -2.14M | -13.60% |
| Q2 2020 Q2Q % growth | 18.31M 79.86% | 14.533M | 3.777M | 25.99% |
| Q1 2020 Q2Q % growth | 15.25M 21.13% | 14.644M | 606K | 4.14% |
| Q4 2019 Q2Q % growth | 17.06M | 15.963M | 1.097M | 6.87% |
| Q3 2019 Q2Q % growth | 13.78M | 12.971M | 809K | 6.24% |
| Q2 2019 Q2Q % growth | 10.18M | 11.084M | -904K | -8.16% |
| Q1 2019 Q2Q % growth | 12.59M | 9.136M | 3.454M | 37.81% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.04% | -33.33% | -12.71% | -12.71% |
| Revenue | -0.91% | 1.69% | -0.11% | -0.34% |